Cart
sales@molnova.com
Platelet Factor 4 (58-70), human
CAS No. 82989-21-7
Platelet Factor 4 (58-70), human( —— )
Catalog No. M30366 CAS No. 82989-21-7
Platelet Factor 4 (58-70), human is a polypeptide based on the 58-70 amino acid sequence of Platelet Factor 4 (pf-4) residues.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 186 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePlatelet Factor 4 (58-70), human
-
NoteResearch use only, not for human use.
-
Brief DescriptionPlatelet Factor 4 (58-70), human is a polypeptide based on the 58-70 amino acid sequence of Platelet Factor 4 (pf-4) residues.
-
DescriptionPlatelet Factor 4 (58-70), human is a polypeptide based on the 58-70 amino acid sequence of Platelet Factor 4 (pf-4) residues.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number82989-21-7
-
Formula Weight1572.97
-
Molecular FormulaC76H133N17O18
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 12.5 mg/mL (7.95 mM)
-
SMILES——
-
Chemical NameSequence:{Pro}{Leu}{Tyr}{Lys}{Lys}{Ile}{Ile}{Lys}{Lys}{Leu}{Leu}{Glu}{Ser}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Jouan V, et al. Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. Blood. 1999 Aug 1;94(3):984-93.
molnova catalog
related products
-
Pivagabine
Pivagabine is a derivative of hydrophobic 4-aminobutyric acid, with neuromodulatory activity. Pivagabine penetrates the blood-brain barrier in rats. Pivagabine antagonizes the effects of foot shock on both GABAA receptor function and corticotropin-releasing factor (CRF) concentrations in rat brain.
-
Nonan-5-ol
Nonan-5-ol (5-nonanol) can be used to synthesize molecular imprinting pseudo-template polymers.
-
6-Hydroxykaempferol ...
6-Hydroxykaempferol 3,6-di-O-glucoside and 6-hydroxykaempferol 3,6,7-tri-O-glucoside can inhibit platelet aggregation induced by collagen, they also show weak inhibitory effects on the adenosine 5'-diphosphate (ADP)- induced platelet aggregation.
